MECHANISMS FOR PITUITARY TUMORIGENESIS

垂体肿瘤发生机制

基本信息

  • 批准号:
    7023096
  • 负责人:
  • 金额:
    $ 27.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-12-15 至 2009-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Pituitary adenomas are common benign neoplasms giving rise to disordered reproductive function, cortisol production, growth, thyroid homeostasis and local central pressure effects. Although determined to be monoclonal, the genetic mechanisms involved in pituitary cell transformation are as yet unresolved. This proposal will continue our work to characterize the properties of PTTG, a novel pituitary tumor-derived protein which has now been identified as the index mammalian securin. Securin regulates equal sister chromatid separation by inactivating separase activity during mitosis. Overexpressed PTTG causes chromosomal instability and aneuploidy. Human and rodent pituitary cells will be transfected with PTTG and degradation-deficient PTTG mutants and mitosis and chromosomal aneuploidy studied by live cell imaging. Transgenic mouse models of pituitary-driven PTTG overexpression (alphaGSU.PTTG) and of PTTG deletion (PTTG-/-) will be used to study the role of PTTG in the pathogenesis of pituicyte progression to hyperplasia and ultimately adenoma formation. The requirement of PTTG for pituitary hyperplasia during pregnancy, estrogen treatment and gonadectomy will be studied. MRI will be used to image transgenic murine pituitary growth in vivo. Effects of PTTG expression on pituitary cell proliferation, apoptosis and transformation will be assessed together with specific pituitary hormone gene expression. To gain further insight into pituitary tumorigenesis and PTTG interaction with other cell cycle regulators, these models will be cross-fertilized with other cell-cycle-disrupted transgenic mice known to develop spontaneous pituitary tumors. These studies will provide mechanistic insight into the role of chromosomal instability in the pathogenesis of pituitary tumors including prolactinomas, acromegaly, Cushing's disease and non-secreting alpha-subunit pituitary adenomas.
描述(由申请方提供):垂体腺瘤是一种常见的良性肿瘤,可引起生殖功能、皮质醇产生、生长、甲状腺稳态和局部中枢压力效应紊乱。虽然确定是单克隆的,但垂体细胞转化中涉及的遗传机制尚未解决。该建议将继续我们的工作,以表征PTTG,一种新的垂体肿瘤衍生蛋白,现已被确定为指数哺乳动物securin的属性。Securin通过在有丝分裂过程中抑制分离酶活性来调节姐妹染色单体的相等分离。过度表达PTTG导致染色体不稳定和非整倍体。将用PTTG和降解缺陷型PTTG突变体转染人和啮齿动物垂体细胞,并通过活细胞成像研究有丝分裂和染色体非整倍性。垂体驱动的PTTG过表达(α GSU·PTTG)和PTTG缺失(PTTG-/-)的转基因小鼠模型将用于研究PTTG在垂体细胞进展为增生和最终腺瘤形成的发病机制中的作用。将研究妊娠期垂体增生、雌激素治疗和性腺切除术对PTTG的需求。将使用MRI对转基因小鼠垂体的体内生长进行成像。PTTG表达对垂体细胞增殖、凋亡和转化的影响将与特异性垂体激素基因表达一起评估。为了进一步深入了解垂体肿瘤发生和PTTG与其他细胞周期调节因子的相互作用,这些模型将与其他已知会发生自发性垂体肿瘤的细胞周期中断的转基因小鼠交叉受精。这些研究将为深入了解染色体不稳定性在垂体瘤(包括泌乳素瘤、肢端肥大症、库欣病和非分泌型α亚单位垂体腺瘤)发病机制中的作用提供机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHLOMO MELMED其他文献

SHLOMO MELMED的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHLOMO MELMED', 18)}}的其他基金

Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
seliciclib 治疗库欣病的 2 期多中心研究 IND 120,848 (10/10/2017)
  • 批准号:
    10003845
  • 财政年份:
    2018
  • 资助金额:
    $ 27.42万
  • 项目类别:
Mechanisms for GH action on epithelial cells
GH 对上皮细胞的作用机制
  • 批准号:
    10578571
  • 财政年份:
    2018
  • 资助金额:
    $ 27.42万
  • 项目类别:
Mechanisms for GH action on epithelial cells
GH 对上皮细胞的作用机制
  • 批准号:
    9893867
  • 财政年份:
    2018
  • 资助金额:
    $ 27.42万
  • 项目类别:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
用选择性 CDK 抑制剂 R-roscovit 治疗垂体库欣病
  • 批准号:
    8773516
  • 财政年份:
    2014
  • 资助金额:
    $ 27.42万
  • 项目类别:
Cedars-Sinai Biobank and Translational Research Core Facility (CS-BRCF)
雪松-西奈生物库和转化研究核心设施 (CS-BRCF)
  • 批准号:
    7935157
  • 财政年份:
    2010
  • 资助金额:
    $ 27.42万
  • 项目类别:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
垂体瘤监测:致病相关性
  • 批准号:
    7606126
  • 财政年份:
    2007
  • 资助金额:
    $ 27.42万
  • 项目类别:
MECHANISMS FOR PITUITARY TUMORIGENESIS
垂体肿瘤发生机制
  • 批准号:
    7606124
  • 财政年份:
    2007
  • 资助金额:
    $ 27.42万
  • 项目类别:
MECHANISMS FOR PITUITARY TUMORIGENESIS
垂体肿瘤发生机制
  • 批准号:
    7376014
  • 财政年份:
    2005
  • 资助金额:
    $ 27.42万
  • 项目类别:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
垂体瘤监测:致病相关性
  • 批准号:
    7376016
  • 财政年份:
    2005
  • 资助金额:
    $ 27.42万
  • 项目类别:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
垂体瘤监测:致病相关性
  • 批准号:
    7206322
  • 财政年份:
    2004
  • 资助金额:
    $ 27.42万
  • 项目类别:

相似国自然基金

RKTG对ERK信号通路的调控和肿瘤生成的影响
  • 批准号:
    30830037
  • 批准年份:
    2008
  • 资助金额:
    190.0 万元
  • 项目类别:
    重点项目

相似海外基金

Targeting Cell Cycle Machinery in Breast Cancer
靶向乳腺癌细胞周期机制
  • 批准号:
    8633711
  • 财政年份:
    2014
  • 资助金额:
    $ 27.42万
  • 项目类别:
The role of cell cycle regulator Cdh1 in carcinogenesis and development of gastrointestinal cancer.
细胞周期调节因子Cdh1在胃肠癌发生和发展中的作用。
  • 批准号:
    23590980
  • 财政年份:
    2011
  • 资助金额:
    $ 27.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of carcinogenesis by dysregulation of cell cycle via abnormal ubiquitin-mediated proteolysis
异常泛素介导的蛋白水解作用导致细胞周期失调的致癌机制
  • 批准号:
    23689074
  • 财政年份:
    2011
  • 资助金额:
    $ 27.42万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    8065522
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    7661914
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
"Cell Cycle Regulation of Eukaryotic DNA Replication"
《真核DNA复制的细胞周期调控》
  • 批准号:
    7990228
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    8268502
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
Maternal-Fetal Nutrition Controls Expression of Cell Cycle Genes in Offspring
母胎营养控制后代细胞周期基因的表达
  • 批准号:
    7876651
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    7848344
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
Maternal-Fetal Nutrition Controls Expression of Cell Cycle Genes in Offspring
母胎营养控制后代细胞周期基因的表达
  • 批准号:
    7753099
  • 财政年份:
    2009
  • 资助金额:
    $ 27.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了